✦ LIBER ✦

3–34 A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

✍ Scribed by Kelly, P; Makumbi, FA; Luo, N.; Seedat, YK; Farthing, MJG

Book ID: 122009586
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 49 KB
Volume: 16
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(05)80232-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Multigene Assay to Predict Recurrence

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

✍ Paik, Soonmyung; Shak, Steven; Tang, Gong; Kim, Chungyeul; Baker, Joffre; Cronin 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 132 KB

A Multigene Assay for Predicting the Rec

A Multigene Assay for Predicting the Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

✍ Cristofanilli, Massimo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Molecular Detection of Micrometastatic B

Molecular Detection of Micrometastatic Breast Cancer in Histopathology—Negative Axillary Lymph Nodes Fails to Predict Breast Cancer Recurrence: A Final Analysis of a Prospective Multi-Institutional Cohort Study

✍ Carla Suzanne Fisher; David J. Cole; Michael Mitas; Elizabeth Garrett-Meyer; Joh 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 314 KB

Molecular Detection of Micrometastatic B

✍ Williams, A.; Balic, M.; Cote, R.J.; Datar, R.H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Long-term Results of Accelerated Partial

Long-term Results of Accelerated Partial Breast Irradiation (APBI) for Early Stage Node Negative Breast Cancer Treated by Balloon Catheter: Evaluation of Loco-regional Recurrence and Cosmesis With Respect to Body Mass Index (BMI)

✍ Ravi, A.; Osian, A.; Sison, C.; Nori, D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

DNA-methylation of the homeodomain trans

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

✍ Sabine Maier; Inko Nimmrich; Thomas Koenig; Serenella Eppenberger-Castori; Inga 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 621 KB